The DOI matches its Crossref record.
The role of natural killer cells in human disease
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 153
- Abo, 1984, Characterization of human granular lymphocyte subpopulations expressing NHK-1 (Leu-7 and Leu-11) antigens in the blood and lymphoid tissues from fetuses, neonates and adults, Eur. J. Immunol., 1, 616, 10.1002/eji.1830140707 · DOI
- Adler, 1988, Interleukin-2 induction of lymphokine-activated killer acute leukemia patients. I. Feasibility of LAK generation in adult patients with active disease and in remission, Blood, 71, 709, 10.1182/blood.V71.3.709.709 · DOI
- Agostini, 1985, Phenotypical and functional analysis of natural killer cells in sarcoidosis, Clin. Immunol. Immunopathol., 37, 262, 10.1016/0090-1229(85)90158-8 · doi:10.1016/0090-1229(85)90158-8
- Alcocer-Varela, 1982, Decreased production of and response to interleukin 2 by cultured lymphocytes from patients with systemic lupus erythematosus, J. Clin. Invest., 69, 1388, 10.1172/JCI110579 · DOI · Paper page
- Aoki, 1987, Low NK syndrome (LNKS): Clinical and immunologic features, Nat. Immun. Cell Growth Regul., 6, 116
- Balch, 1983, Depressed levels of granular lymphocytes with natural killer (NK) cell function in 247 cancer patients, Ann. Surg., 198, 192, 10.1097/00000658-198308000-00014 · DOI
- Barlozzari, 1983, In vivo role of natural killer cells: Involvement of large granular lymphocytes in the clearance of tumor cells in anti-asialo GM1-treated rats, J. Immunol., 131, 1024, 10.4049/jimmunol.131.2.1024 · DOI · Paper page
- Bast, 1984, Immunologic approaches to the management of ovarian carcinoma, Semin. Oncol., 11, 264
- Baumann, 1986, Correlation of circulating natural killer cell count with prognosis in large cell lymphoma, Cancer, 57, 2309, 10.1002/1097-0142(19860615)57:12<2309::AID-CNCR2820571212>3.0.CO;2-H · doi:10.1002/1097-0142(19860615)57:12<2309::aid-cncr2820571212>3.0.co;2-h
- Benczur, 1980, Dysfunction of natural killer cells in multiple sclerosis: A possible pathogenetic factor, Clin. Exp. Immunol., 39, 657
- Biron, 1982, Activation and role of natural killer cells in virus infections, Med. Microbiol. Immunol., 170, 155, 10.1007/BF02298196 · doi:10.1007/bf02298196
- Biron, 1983, Increase in NK cell number and turnover rate during acute viral infections, J. Immunol., 131, 1539, 10.4049/jimmunol.131.3.1539 · DOI
- Biron, 1988, Susceptibility to viral infections in an individual with a complete lack of natural killer cells, Nat. Immun. Cell Growth Regul., 7, 47
- Blomgren, 1980, Natural killer activity in peripheral lymphocyte population following local radiation therapy, Acta Radiol. Oncol., 19, 139, 10.3109/02841868009130145 · DOI
- Bonavida, 1986, Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. I. Defective trigger of NK cells for NKCF production by target cells, and partial restoration by IL-2, J. Immunol., 137, 1157, 10.4049/jimmunol.137.4.1157 · DOI
- Borysiewicz, 1985, Lysis of human cytomegalovirus infected fibroblasts by natural killer cells: Demonstration of an interferon-independent component requiring expression of early viral proteins and characterization of effector cells, J. Immunol., 134, 2695, 10.4049/jimmunol.134.4.2695 · DOI
- Bowden, 1987, Natural cytotoxic activity against cytomegalovirus-infected target cells following marrow transplantation, Transplantation, 44, 504, 10.1097/00007890-198710000-00009 · DOI
- Brenner, 1987, Human large granular lymphocytes induce immunoglobulin synthesis after bone marrow transplantation, Eur. J. Immunol., 17, 43, 10.1002/eji.1830170108 · DOI
- Bukowski, 1983, Natural killer cell depletion enhances virus synthesis and virus-induced hepatitis in vivo, J. Immunol., 131, 1531, 10.4049/jimmunol.131.3.1531 · DOI · Paper page
- Caliguiri, 1987, Phenotypic and functional deficiency of natural killer cells in patients with chronic fatigue syndrome, J. Immunol., 139, 3306, 10.4049/jimmunol.139.10.3306 · DOI · Paper page
- Chan, 1986, Heterogeneity of large granular lymphocyte proliferations: Delineation of two major subtypes, Blood, 68, 1142, 10.1182/blood.V68.5.1142.1142 · DOI
- Choe, 1987, natural killer cell activity of prostatic cancer patients, Cancer Invest., 5, 285, 10.1080/07357908709170101 · doi:10.1080/07357908709170101
- Cortesina, 1988, Treatment of recurrent squamous cell carcinoma of head and neck with low doses of interleukin-2 (IL2) injected perilymphatically, Cancer, 62, 2482, 10.1002/1097-0142(19881215)62:12<2482::AID-CNCR2820621205>3.0.CO;2-9 · doi:10.1002/1097-0142(19881215)62:12<2482::aid-cncr2820621205>3.0.co;2-9
- Cunningham-Rundles, 1981, Natural cytotoxicity of peripheral blood lymphocytes and regional lymph node cells in breast cancer in women, JNCI, 67, 585
- Cuturi, M. C., Anegon, I., Sherman, F., Loudon, R., Clark, S. C., Perussia, B., and Trinchieri, G., Production of hematopoietic colony-stimulating factors by human natural killer cells. J. Exp. Med., in press.
- del Prete, 1986, Cytolytic T lymphocytes with natural killer activity in thyroid infiltrate of patients with Hashimoto's thyroiditis: Analysis at clonal level, J. Clin. Endocrinol. Metab., 62, 52, 10.1210/jcem-62-1-52 · doi:10.1210/jcem-62-1-52
- Dickenson, 1985, Natural killer cell activity in childhood acute lymphoblastic leukemia in remission, Brit. J. Haematol., 59, 45, 10.1111/j.1365-2141.1985.tb02962.x · DOI
- Eby, 1988, Natural killer cell activity as a marker of immune dysfunction in the chronic fatigue syndrome, Nat. Immun. Cell Growth Regul., 7, 48
- Edelman, 1989, AIDS: A syndrome of immune dysregulation, dysfunction and deficiency, FASEB J., 3, 22, 10.1096/fasebj.3.1.2562947 · DOI
- Egan, 1983, Natural killer cells in systemic lupus erythematosus: Abnormal numbers and functional immaturity of HNK1+ cells, Arthritis Rheum., 26, 623, 10.1002/art.1780260508 · doi:10.1002/art.1780260508
- Fauci, 1988, The human immunodeficiency virus: Infectivity and mechanisms of pathogenesis, Science, 239, 617, 10.1126/science.3277274 · DOI · Paper page
- Fitzgerald, 1985, Human natural killer cells limit replication of herpes simplex virus type 1 in vitro, J. Immunol., 134, 2666, 10.4049/jimmunol.134.4.2666 · DOI
- Fox, 1986, Detection of Epstein-Barr virus-associated antigens and DNA in salivary gland biopsies from patient with Sjogren's syndrome, J. Immunol., 137, 3162, 10.4049/jimmunol.137.10.3162 · doi:10.4049/jimmunol.137.10.3162
- Frizzera, 1981, Polymorphic diffuse B-cell hyperplasia in lymphomas in renal transplant recipients, Cancer Res., 41, 4262
- Froelich, 1989, Deficient interleukin-2 activated killer cell cytotoxicity in patients with systemic lupus erythematosus, Clin. Immunol. Immunopathol., 50, 132, 10.1016/0090-1229(89)90228-6 · doi:10.1016/0090-1229(89)90228-6
- Frydecka, 1986, Early effects of radiotherapy on natural killer activity in patients with gynecological malignancies, Folia Haematol., 113, 499
- Fujimori, 1987, Effect of lymphokine-activated killer cell fraction on the development of human hematopoietic progenitor cells, Cancer Res., 48, 534
- Gaspar, 1988, Role of interleukin 2 in inducing normalization of natural killer activity in systemic lupus erythematosus, Clin. Immunol. Immunopathol., 49, 204, 10.1016/0090-1229(88)90110-9 · doi:10.1016/0090-1229(88)90110-9
- Gatti, 1987, Circadian changes in human natural killer-cell activity, Prog. Clin. Biol. Res. A, 227, 399
- Ginsburg, 1983, Impaired natural killer cell activity in patients with inflammatory bowel disease: Evidence for a qualitative defect, Gastroenterology, 85, 846, 10.1016/0016-5085(83)90434-1 · DOI
- Gonzalez-Amaro, 1984, Natural killer cell-mediated activity in mixed connective tissue disease and its response to induction by interleukin 2, J. Clin. Immunoo., 4, 273, 10.1007/BF00915294 · doi:10.1007/bf00915294
- Gonzales-Amaro, 1987, Natural killer cell activity in dermatomyositis-polymyositis, J. Rheumatol., 14, 307
- Gorelik, 1982, Role of NK cells in the control of metastatic spread and growth of tumor cells in mice, Int. J. Cancer, 30, 107, 10.1002/ijc.2910300118 · DOI · Paper page
- Goss, 1985, Effect of natural killer cells on syngeneic bone marrow: In vitro and in vivo studies demonstrating graft failure due to NK cells in an identical twin treated by bone marrow transplantation, Blood, 66, 1043, 10.1182/blood.V66.5.1043.1043 · DOI
- Haliotis, 1980, Chediak-Higashi gene in humans. I. Impairment of natural killer function, J. Exp. Med., 151, 1029, 10.1084/jem.151.5.1039 · DOI
- Hanna, 1982, Role of natural killer cell in control of cancer metastasis, Cancer Metastasis Rev., 1, 45, 10.1007/BF00049480 · DOI · Paper page
- Hanto, 1985, Epstein-Barr virus, immunodeficiency, and B cell lymphoproliferation, Transplantation, 39, 461, 10.1097/00007890-198505000-00001 · doi:10.1097/00007890-198505000-00001
- Harris, 1976, The effect of immunosuppressive chemotherapy on immune function in patients with malignant disease, Cancer, 37, 1058, 10.1002/1097-0142(197602)37:2+<1058::AID-CNCR2820370813>3.0.CO;2-O · doi:10.1002/1097-0142(197602)37:2+<1058::aid-cncr2820370813>3.0.co;2-o
- Hayward, 1986, Cellular interactions in the lysis of varicellazoster virus infected human fibroblasts, Clin. Exp. Immunol., 63, 141
- Henderson, 1980, Cancer of the breast: The past decade, N. Engl. J. Med., 30, 302
- Herberman, 1979, Augmentation by interferon of human natural and antibody dependent cell-mediated cytotoxicity, Nature (London), 277, 221, 10.1038/277221a0 · DOI · Paper page
- Herberman, 1981, Natural killer cells, their role in defense against disease, Science, 214, 24, 10.1126/science.7025208 · DOI · Paper page
- Herberman, 1987, Lymphokine-activated killer cell activity: Characteristics of effector cells and their progenitors in blood and spleen, Immunol. Today, 8, 178, 10.1016/0167-5699(87)90035-1 · doi:10.1016/0167-5699(87)90035-1
- Hercend, 1986, Characterization of natural killer cells with anti-leukemia activity following allogeneic bone marrow transplantation, Blood, 67, 722, 10.1182/blood.V67.3.722.722 · DOI
- Hercend, 1988, Characteristics and uses of natural killer cells, Immunol. Today, 9, 291, 10.1016/0167-5699(88)91317-5 · DOI · Paper page
- Herman, 1985, Defective interleukin-1 production by natural killer cells of patients with cancer, Cancer Immunol. Immunother., 19, 148, 10.1007/BF00199724 · doi:10.1007/bf00199724
- Herrmann, 1987, In vitro regulation of human hematopoiesis by natural killer cells: Analysis at a clonal level, Blood, 69, 246, 10.1182/blood.V69.1.246.246 · DOI
- Hersey, 1979, Low natural killer-cell activity in familial melanoma patients and their relatives, Brit. J. Cancer, 40, 113, 10.1038/bjc.1979.147 · DOI
- Hirai, 1986, Natural killer (NK) cell activity and its in vitro response to interferon-alpha in chronic liver diseases and hepatocellular carcinoma, Liver, 6, 212, 10.1111/j.1600-0676.1986.tb01068.x · doi:10.1111/j.1600-0676.1986.tb01068.x
- Hirofuji, 1987, Natural killer inactivated killer activities in chronic liver disease and hepatocellular carcinoma: Evidence for a decreased lymphokine-induced activity of effector cells, Clin. Exp. Immunol., 68, 348
- Ho, 1988, The frequency of Epstein-Barr virus infection and associated lymphoproliferative syndrome after transplantation and its manifestation s in children, Transplantation, 45, 719, 10.1097/00007890-198804000-00011 · doi:10.1097/00007890-198804000-00011
- Hoffman, 1980, Natural killer function in systemic lupus erythematosus, Arthritis Rheum., 23, 30, 10.1002/art.1780230106 · DOI
- Hokland, 1988, Natural killer function following allogeneic bone marrow transplantation: Very early reemergence but strong dependence of cytomegalovirus infection, Transplantation, 45, 1080, 10.1097/00007890-198806000-00016 · DOI
- Holmberg, 1984, The effect of natural killer cells on the development of syngeneic hematopoietic progenitors, J. Immunol., 133, 2933, 10.4049/jimmunol.133.6.2933 · DOI
- Holmes, 1988, Chronic fatigue syndrome: A working case definition, Ann. Int. Med., 108, 387, 10.7326/0003-4819-108-3-387 · DOI · Paper page
- Hussain, 1987, Evidence that the reduced numbers of natural killer cells in Type 1 (insulin-dependent) diabetes may be genetically determined, Diabetologica, 30, 907, 10.1007/BF00295872 · DOI
- Introna, 1983, Natural killer cells in human solid tumors, Cancer Metastasis Rev., 2, 337, 10.1007/BF00048566 · doi:10.1007/bf00048566
- Jondal, 1987, The human NK cell: A short overview and a hypothesis on NK recognition, Clin. Exp. Immunol., 70, 255
- Jones, 1985, Evidence for active Epstein-Barr virus infection in patients with persistent unexplained illnesses: Elevated anti-early antigen antibodies, Ann. Int. Med., 102, 127, 10.7326/0003-4819-102-1- · DOI · Paper page
- Kasahara, 1983, Capacity of human large granular lymphocytes (LGL) to produce multiple lymphokines: Interleukin 2, interferon, and colony stimulating factor, J. Immunol., 131, 2379, 10.4049/jimmunol.131.5.2379 · DOI
- Katz, 1987, Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. II. Normal antibody-dependent cellular cytotoxicity (ADCC) mediated by effector cells defective in natural killer (NK) cytotoxicity, J. Immunol., 139, 55, 10.4049/jimmunol.139.1.55 · doi:10.4049/jimmunol.139.1.55
- Katz, 1982, Abnormal natural killer cell activity in systemic lupus erythematosus: An intrinsic defect in the lytic event, J. Immunol., 129, 1966, 10.4049/jimmunol.129.5.1966 · doi:10.4049/jimmunol.129.5.1966
- Kay, 1984, Impaired natural killer (NK) activity in patients with chronic lymphocytic leukemia is associated with a deficiency of azurophilic cytoplasmic granules in putative NK cells, Blood, 63, 305, 10.1182/blood.V63.2.305.305 · doi:10.1182/blood.v63.2.305.305
- Kay, 1986, Natural killer cells, CRC Crit. Rev. Clin. Lab. Sci., 22, 343
- Kedar, 1988, Therapy of advanced solid tumors in mice using chemotherapy in combination with interleukin 2 with and without lymphokine-activated killer cells, Israel J. Med. Sci., 24, 494
- Kohl, 1986, The genetic deficiency of leukocyte surface glycoprotein Mac-1, LFA-1, p150, 95 in humans is associated with defective antibody-dependent cellular cytotoxicity in vitro and defective protection against herpes simplex infection in vivo, J. Immunol., 137, 1688, 10.4049/jimmunol.137.5.1688 · doi:10.4049/jimmunol.137.5.1688
- Lanier, 1983, Subpopulations of human natural killer cells defined by expression of the Leu-7 (HNK-1) and Leu-11 (NK-15) antigens, J. Immunol., 131, 1789, 10.4049/jimmunol.131.4.1789 · DOI · Paper page
- Levy, 1985, Prognostic risk assessment in primary breast cancer by behavioral and immunological parameters, Health Psychol., 4, 99, 10.1037/0278-6133.4.2.99 · doi:10.1037/0278-6133.4.2.99 · Paper page
- Levy, 1987, Correlation of stress factors with sustained depression of natural killer cell activity and predicted prognosis in patients with breast cancer, J. Clin. Oncol., 5, 348, 10.1200/JCO.1987.5.3.348 · DOI · Paper page
- Levy, S., Herberman, R., Simons, A., Whiteside, T., Lee, J., McDonald, R., and Beadle, M., Persistently low natural killer cell activity: Immunological, hormonal, and psychological correlates. Nat. Immun. Cell Growth Regul., in press.
- Lin, 1987, Natural killer cell activity in lung cancer patients, Chest, 92, 1022, 10.1378/chest.92.6.1022 · doi:10.1378/chest.92.6.1022
- Liashenko, 1986, Functional activity of natural killers in viral hepatitis, A. Ter. Arhh., 58, 60
- Long, 1988, Lymphokine-activated killer cell purging of leukemia cells from bone marrow prior to syngeneic transplantation, Transplantation, 46, 433, 10.1097/00007890-198809000-00020 · doi:10.1097/00007890-198809000-00020
- Lopez, 1982, Studies of the cell lineage of the effector cells that spontaneously lyse HSV-1 infected fibroblasts (NK {HSV-1}), J. Immunol., 129, 824, 10.4049/jimmunol.129.2.824 · DOI
- Lopez, 1983, Severe acquired immune deficiency syndrome in male homosexuals: Diminished capacity to make interferon alpha in vitro associated with severe opportunistic infections, J. Infect. Dis., 148, 962, 10.1093/infdis/148.6.962 · DOI
- Lotz, 1986, Release of lymphokines after Epstein-Barr virus infection in vitro. I. Sources of and kinetics of production of interferons and interleukins in normal humans, J. Immunol., 136, 3636, 10.4049/jimmunol.136.10.3636 · doi:10.4049/jimmunol.136.10.3636
- Lotzova, 1987, Induction of NK cell activity against fresh leukemia in culture with interleukin 2, J. Immunol., 138, 718, 10.4049/jimmunol.138.8.2718 · DOI · Paper page
- Lotzova, 1987, Impaired NK cell profile in leukemia patients, Vol. 2, 29
- Majewski, 1987, Natural killer cell activity of peripheral blood mononuclear cells from patients with various forms of systemic scleroderma, Brit. J. Dermatol., 116, 1, 10.1111/j.1365-2133.1987.tb05784.x · DOI
- Maluish, 1983, Depression of natural killer cytotoxicity after in vivo administration of recombinant leukocyte interferon, J. Immunol., 131, 5030, 10.4049/jimmunol.131.1.503 · DOI
- Mangan, 1984, Natural killer cells suppress human erythroid stem cell proliferation in vitro, Blood, 63, 260, 10.1182/blood.V63.2.260.260 · doi:10.1182/blood.v63.2.260.260
- Matera, 1983, Natural killer activity and low affinity E rosettes in acute leukemia, Acta Haematol., 70, 158, 10.1159/000206716 · doi:10.1159/000206716
- Melder, 1989, Lymphokine-activated killer (LAK) cell cytotoxicity against HIV-infected human monocytes, FASEB J, 3, A1283
- Miller, 1988, Reduced natural killer cell activity in patients with systemic sclerosis, Arthritis Rheum., 31, 1515, 10.1002/art.1780311208 · DOI
- Minato, 1982, Studies of the functions of natural killer-interferon system in patients with Sjogren's syndrome, J. Clin. Invest., 69, 581, 10.1172/JCI110484 · doi:10.1172/jci110484
- Mitchell, 1984, Spontaneous and interferon resistant natural killer cell anergy in AIDS, AIDS Res., 1, 221, 10.1089/aid.1.1983.1.221 · doi:10.1089/aid.1.1983.1.221
- Mullbacher, 1984, An improved colorimetric assay for T cell cytotoxicity in vitro, J. Immunol. Methods, 68, 205, 10.1016/0022-1759(84)90151-0 · doi:10.1016/0022-1759(84)90151-0
- Nesbit-Brown, E., and Lee, J., Fluorescence-based measurement of cytolytic T cell activity. J. Immunol. Methods, in press.
- Newhonen, 1987, Increased number of functionally defective large granular lymphocytes in lymphoma patients, Nat. Immun. Cell Growth Regul., 6, 57
- Niederwieser, 1987, Rapid reappearance of large granular lymphocytes (LGL) with concomitant reconstitution of natural killer (NK) activity after human bone marrow transplantation (BMT), Brit. J. Hematol., 65, 301, 10.1111/j.1365-2141.1987.00295.x-i1 · doi:10.1111/j.1365-2141.1987.00295.x-i1
- Ortaldo, 1984, Heterogeneity of natural killer cells, Annu. Rev. Immunol., 2, 359, 10.1146/annurev.iy.02.040184.002043 · doi:10.1146/annurev.iy.02.040184.002043 · Paper page
- Ortaldo, 1986, Lymphokine-activated killer cells: Analysis of progenitors and effectors, J. Exp. Med., 164, 1193, 10.1084/jem.164.4.1193 · doi:10.1084/jem.164.4.1193
- Oshimi, 1982, Natural killer cell activity in untreated SLE, Ann. Rheum. Dis., 41, 417, 10.1136/ard.41.4.417 · doi:10.1136/ard.41.4.417
- Oshimi, 1986, Cytotoxicity of interleukin 2-activated lymphocytes for leukemia and lymphoma cells, Blood, 68, 938, 10.1182/blood.V68.4.938.938 · doi:10.1182/blood.v68.4.938.938
- Papa, 1988, Combined effects of chemotherapy and interleukin 2 in the therapy of mice with advanced pulmonary tumors, Cancer Res., 48, 122
- Pederson, 1988, Impaired release of natural killer cytotoxic factor in patients with primary Sjogren's syndrome, Clin. Exp. Immunol., 72, 299
- Phillips, 1987, In vivo and in vitro activation of natural killer cells in advanced cancer patients undergoing combined recombinant interleukin 2 LAK cell therapy, J. Clin. Oncol., 5, 1933, 10.1200/JCO.1987.5.12.1933 · DOI
- Pistoia, 1985, Large granular lymphocytes have a promoting activity on human peripheral blood erythroid burst-forming units, Blood, 65, 464, 10.1182/blood.V65.2.464.464 · DOI
- Plaeger-Marshall, 1987, Alterations in cytotoxic and phenotypic subsets of natural killer cells in acquired immune deficiency syndrome (AIDS), J. Clin. Immunol., 7, 16, 10.1007/BF00915420 · doi:10.1007/bf00915420
- Pollack, 1982, In vivo reduction of NK activity with anti-NK1 serum: Direct evaluation of NK cells in tumor clearance, Int. J. Cancer, 29, 203, 10.1002/ijc.2910290215 · DOI
- Pross, 1976, Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. I. The effect of malignant disease, Int. J. Cancer, 18, 593, 10.1002/ijc.2910180508 · DOI
- Pross, 1981, Spontaneous human lymphocyte mediated cytotoxicity against tumor target cell. IX. The quantitation of natural killer cell activity, J. Clin. Immunol., 1, 51, 10.1007/BF00915477 · DOI · Paper page
- Purtilo, 1981, Documentation of Epstein-Barr virus infection in immunodeficient patients with life-threatening lymphoproliferative diseases by clinical, virological and immunopathological studies, Cancer Res., 41, 4226
- Roder, 1980, A new immunodeficiency disorder in humans involving NK cells, Nature (London), 284, 553, 10.1038/284553a0 · DOI · Paper page
- Rook, 1983, Interleukin-2 enhances the depressed natural killer and cytomegalovirus-specific cytotoxic activities of lymphocytes from patients with the acquired immune deficiency syndrome, J. Clin. Invest., 72, 398, 10.1172/JCI110981 · doi:10.1172/jci110981
- Rooney, 1986, Natural killer cell activity following T cell depleted allogeneic bone marrow transplantation, Brit. J. Haematol., 62, 13, 10.1111/j.1365-2141.1986.tb02952.x · DOI
- Rosenberg, 1988, Immunotherapy of cancer using interleukin 2: Current status and future prospects, Immunol. Today, 9, 58, 10.1016/0167-5699(88)91261-3 · doi:10.1016/0167-5699(88)91261-3
- Rosenberg, 1987, A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin 2 or high dose interleukin 2 alone, N. Engl. J. Med., 316, 889, 10.1056/NEJM198704093161501 · DOI · Paper page
- Rousset, 1986, Studies of EBV-lymphoid cell interactions in two patients with the X-linked lymphoproliferative syndrome: Normal EBV-specific HLA-restricted cytotoxicity, Clin. Exp. Immunol., 63, 280
- Ruco, 1983, Severe deficiency of natural killer activity in the peripheral blood of patients with hairy cell leukemia, Blood, 61, 1132, 10.1182/blood.V61.6.1132.1132 · doi:10.1182/blood.v61.6.1132.1132
- Ruscetti, 1986, Analysis of effector mechanisms against HTLV-1 and HLTV-IIILAV infected lymphoid cells, J. Immunol., 136, 3619, 10.4049/jimmunol.136.10.3619 · doi:10.4049/jimmunol.136.10.3619
- Saemundsen, 1981, Epstein-Barr virus carrying lymphoma in a patient with ataxia telangiectasia, Brit. Med. J., 282, 425, 10.1136/bmj.282.6262.425 · doi:10.1136/bmj.282.6262.425
- Salup, 1986, Adjuvant immunotherapy of established murine renal cancer by interleukin 2 stimulated cytotoxic lymphocytes, Cancer Res., 46, 3358
- Santoli, 1978, Cell-mediated cytotoxicity against virus-infected target cells in humans. I. Characterization of the effector lymphocytes, J. Immunol., 121, 526, 10.4049/jimmunol.121.2.526 · DOI
- Schantz, 1986, Natural killer cell activity in head and neck cancer: A clinical assessment, JNCI, 77, 869
- Schantz, 1987, Multi modality therapy and distant metastasis: The impact of natural killer cell activity, Arch. Otolaryngol. Head Neck Surg., 113, 1207, 10.1001/archotol.1987.01860110073011 · DOI
- Schantz, 1987, Evidence for the role of natural immunity and the control of metastatic spread of head and neck cancer, Cancer Immunol. Immunother., 25, 141, 10.1007/BF00199955 · DOI
- Schwartz, 1959, The effect of 6-mercaptopurine on primary and secondary immune responses, J. Clin. Invest., 38, 1394, 10.1172/JCI103915 · doi:10.1172/jci103915
- Sibbitt, 1983, Natural killer cells in systemic lupus erythematosus: Defects in effector lytic activity and response to interferon and interferon inducers, J. Clin. Invest., 71, 1230, 10.1172/JCI110872 · doi:10.1172/jci110872
- Silagi, 1986, Successful immunotherapy of mouse melanoma in sarcoma with recombinant interleukin and cyclophosphamide, J. Biol. Response Modif., 5, 411
- Sirianni, 1988, Mechanism of defective natural killer cell activity in patients with AIDS is associated with defective distribution of tubulin, J. Immunol., 140, 2565, 10.4049/jimmunol.140.8.2565 · DOI
- Son, 1982, Depressed natural killer cell activity in patients with hepatocellular carcinoma: In vitro effects of interferon and levamisol, Cancer, 50, 2820, 10.1002/1097-0142(19821215)50:12<2820::AID-CNCR2820501222>3.0.CO;2-# · doi:10.1002/1097-0142(19821215)50:12<2820::aid-cncr2820501222>3.0.co;2-#
- Starzl, 1985, Liver stability of lymphomas and lymphoproliferative lesions developing under cyclosporine-steroid therapy, Lancet, 1, 583
- Steinhauer, 1982, Effective natural cytotoxicity in patients with cancer: Normal number of effector cells but decreased recycling capacity in patients with advanced disease, J. Immunol., 129, 2255, 10.4049/jimmunol.129.5.2255 · doi:10.4049/jimmunol.129.5.2255
- Straus, 1985, Persisting illness in fatigue in adults with evidence of Epstein-Barr virus infection, Ann. Int. Med., 102, 7, 10.7326/0003-4819-102-1-7 · DOI · Paper page
- Strayer, 1984, Low natural cytotoxicity of peripheral blood mononuclear cells in individuals with high familial incidences of cancer, Cancer Res., 44, 370
- Strayer, 1986, Familial occurrence of breast cancer is associated with reduced natural killer cytotoxicity, Breast Cancer Res. Treat., 7, 187, 10.1007/BF01806249 · DOI
- Sullivan, 1980, Deficient natural killer cell activity in X-linked lymphoproliferative syndrome, Science, 210, 543, 10.1126/science.6158759 · DOI
- Takasugi, 1977, Decline of natural nonselective cell-mediated cytotoxicity in patients with tumor progression, Cancer Res., 37, 413
- Takeda, 1987, Selective impairment of alpha interferon-mediated natural killer augmentation in Sjogren's syndrome: Differential effects of alpha interferon, gamma interferon and interleukin 2 on cytolytic activity, Clin. Exp. Immunol., 70, 354
- Tartter, 1986, Changes in peripheral T cell subsets and natural killer cytotoxicity in relation to colon rectal cancer surgery, Cancer Detect. Prev., 9, 359
- Thoen, 1987, Natural killer (NK) cells at inflammatory sites of patients with rheumatoid arthritis and IgM rheumatoid factor-positive polyarticular juvenile rheumatoid arthritis, Clin. Rheumatol., 6, 215, 10.1007/BF02201027 · doi:10.1007/bf02201027
- Tichatschek, 1988, Long-term influence of adjuvant therapy on natural killer cell activity in breast cancer, Cancer Immunol. Immunother., 27, 278, 10.1007/BF00205452 · doi:10.1007/bf00205452
- Tilden, 1986, Demonstration of NK cell-mediated lysis of varicella-zoster virus (VZV)-infected cells: Characterization of the effector cells, J. Immunol., 136, 4243, 10.4049/jimmunol.136.11.4243 · DOI
- Timonen, 1981, Characteristics of human large granular lymphocytes and relationship to natural killer and K cells, J. Exp. Med., 153, 569, 10.1084/jem.153.3.569 · DOI · Paper page
- Todd, 1988, The CC11CD18 leukocyte glycoprotein deficiency, Hematol. Oncol. Clin. North Amer., 2, 13, 10.1016/S0889-8588(18)30629-4 · DOI
- Tonnesen, 1983, Natural killer cell activity during premedication, anesthesia, and surgery, Acta Anaesthesiol. Scand., 27, 238, 10.1111/j.1399-6576.1983.tb01943.x · DOI
- Trinchieri, 1984, Human natural killer cells: Biologic and pathologic aspects, Lab. Invest., 50, 489
- Tursz, 1982, Low natural killer cell activity in patients with malignant lymphoma, Cancer, 50, 2333, 10.1002/1097-0142(19821201)50:11<2333::AID-CNCR2820501119>3.0.CO;2-W · doi:10.1002/1097-0142(19821201)50:11<2333::aid-cncr2820501119>3.0.co;2-w
- Welsh, 1986, Regulation of virus infections by natural killer cells, Nat. Immun. Cell Growth Regul., 5, 169
- West, 1987, Constant-infusion recombinant interleukin 2 in adoptive immunotherapy of advanced cancer, N. Engl. J. Med., 316, 898, 10.1056/NEJM198704093161502 · doi:10.1056/nejm198704093161502
- Ziegler, 1981, Deficiency of natural killer cell activity in patients with chronic lymphocytic leukemia, Int. J. Cancer, 27, 321, 10.1002/ijc.2910270310 · doi:10.1002/ijc.2910270310
- Zielinski, 1986, Impaired primary, but not secondary, immune response in breast cancer patients under adjuvant chemotherapy, Cancer, 58, 1648, 10.1002/1097-0142(19861015)58:8<1648::AID-CNCR2820580812>3.0.CO;2-E · doi:10.1002/1097-0142(19861015)58:8<1648::aid-cncr2820580812>3.0.co;2-e
Cited by
Exercise and the immune system: regulation, integration, and adaptation
Pedersen, B. K., & Hoffman-Goetz, L. (2000) · Physiological Reviews · doi:10.1152/physrev.2000.80.3.1055 · Cited by 1,710
Ale, M. T., Mikkelsen, J. D., & Meyer, A. S. (2011) · Marine Drugs · doi:10.3390/md9102106 · Cited by 779
Posttraumatic Stress Symptoms, Intrusive Thoughts, Loss, and Immune Function after Hurricane Andrew
Ironson, G., Wynings, C., Schneiderman, N., Baum, A., Rodriguez, M., Greenwood, D., Benight, C., Antoni, M., LaPerriere, A., Huang, H.-S., et al. (1997) · Psychosomatic Medicine · doi:10.1097/00006842-199703000-00003 · Cited by 435
Buchwald, D., Cheney, P. R., Peterson, D. L., Henry, B., Wormsley, S. B., Geiger, A., Ablashi, D. V., Salahuddin, S. Z., Saxinger, C., Biddle, R., et al. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-2-103 · Cited by 384
Morphine Inhibits Spontaneous and Cytokine-enhanced Natural Killer Cell Cytotoxicity in Volunteers
Yeager, M. P., Colacchio, T. A., Yu, C. T., Hildebrandt, L., Howell, A. L., Weiss, J., & Guyre, P. M. (1995) · Anesthesiology · doi:10.1097/00000542-199509000-00008 · Cited by 305
Metadata
- Authors
- Whiteside, T. L., & Herberman, R. B.
- Venue
- Clinical Immunology and Immunopathology
- Publisher
- Elsevier BV
- Published
- 1989-10
- Volume
- 53
- Issue
- 1
- Pages
- 1-23
- ISSN
- 0090-1229 (ISSN-L)
- OpenAlex
- W2074846327
- Cited by
- 217
- References
- 0
- FWCI
- 5.37
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The role of natural killer cells in human disease. https://app.cochat.ai/papers/10.1016/0090-1229(89)90096-2
- The paper
- Whiteside, T. L., & Herberman, R. B. (1989). The role of natural killer cells in human disease. Clinical Immunology and Immunopathology. https://doi.org/10.1016/0090-1229(89)90096-2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.